AIMCA
BBIO icon

Alberta Investment Management Corp (AIMCo)’s BridgeBio Pharma BBIO Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-29,133
Closed -$738K – 770
2024
Q2 		$738K Buy
29,133
+4,908
+20% +$134K 0.01% 578
2024
Q1 		$749K Buy
+24,225
New +$824K 0.01% 730
2022
Q1 		– Sell
-1,000,000
Closed -$16.7M – 1299
2021
Q4 		$16.7M Buy
1,000,000
+700,000
+233% +$29.6M 0.1% 206
2021
Q3 		$14.1M Buy
+300,000
New +$16.1M 0.12% 186

Other funds holding BBIO

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s BBIO Position: Q3 2024 in Review

Alberta Investment Management Corp (AIMCo) sold out of BridgeBio Pharma (BBIO) in Q3 2024, closing a stake of 29,133 shares — an estimated $738K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in BBIO in Q3 2021 and held it in 4 quarters. The position peaked at $16.7M in Q4 2021. 253 funds tracked by Wall St. Rank hold BBIO as of Q3 2024.

  • Alberta Investment Management Corp (AIMCo) reported no remaining BridgeBio Pharma position as of Q3 2024 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 29,133 BridgeBio Pharma shares in Q3 2024, an estimated $738K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in BridgeBio Pharma in Q3 2021 and held it in 4 quarters.
  • Alberta Investment Management Corp (AIMCo)'s BridgeBio Pharma position peaked at $16.7M in Q4 2021.
  • 253 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2024.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2024, filed 5 Nov 2024.